EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2021-12-14

NEXT DAY DISCLOSURE RETURN

1299

2021-12-08

NEXT DAY DISCLOSURE RETURN

1285

2021-12-07

NEXT DAY DISCLOSURE RETURN

1291

2021-12-06

NEXT DAY DISCLOSURE RETURN

1268

2021-12-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2021

1199

2021-11-24

NEXT DAY DISCLOSURE RETURN

1327

2021-11-23

NEXT DAY DISCLOSURE RETURN

1289

2021-11-22

NEXT DAY DISCLOSURE RETURN

1298

2021-11-19

NEXT DAY DISCLOSURE RETURN

1336

2021-11-18

NEXT DAY DISCLOSURE RETURN

1303

2021-11-16

NEXT DAY DISCLOSURE RETURN

1289

2021-11-15

NEXT DAY DISCLOSURE RETURN

1329

2021-11-12

NEXT DAY DISCLOSURE RETURN

1351

2021-11-10

VOLUNTARY ANNOUNCEMENT FIRST PATIENT FIRST VISIT COMPLETED IN A PHASE 3 CLINICAL STUDY IN THE PRC IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1277

2021-11-08

NEXT DAY DISCLOSURE RETURN

1280

2021-11-05

NEXT DAY DISCLOSURE RETURN

1311

2021-11-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2021

1129

2021-11-02

NEXT DAY DISCLOSURE RETURN

1307

2021-11-01

NEXT DAY DISCLOSURE RETURN

1271

2021-10-29

NEXT DAY DISCLOSURE RETURN

1328

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT